Developing the evidence base for evaluating dementia training in NHS hospitals (DEMTRAIN): a mixed-methods study protocol
Faraz Ahmed(Lancaster University), Siobhán Reilly(University of Bradford), Alistair Burns(University of Manchester), Ruth Elvish(University of Manchester), David Reeves(Manchester Academic Health Science Centre), John Keady(Greater Manchester Mental Health NHS Foundation Trust), Caroline Swarbrick(Lancaster University), Andrew Harding(Lancaster University), Fiona Holland(Manchester Academic Health Science Centre), Linda Davies(University of Manchester), Hazel Morbey(Lancaster University), Simon Burrow(University of Manchester), Iracema Leroi(Trinity College Dublin), Mark Hann(Manchester Academic Health Science Centre)
Cited by 4
Related Papers
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223